Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms
David L. Jaye, Cissy Geigerman, Marco Herling, et al.
Modern Pathology (2006) Vol. 19, Iss. 12, pp. 1555-1562
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
Dharminder Chauhan, Ajita Singh, Mohan Brahmandam, et al.
Cancer Cell (2009) Vol. 16, Iss. 4, pp. 309-323
Open Access | Times Cited: 271
Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis
Dmitri I. Kotov, Ophelia V. Lee, Stefan A. Fattinger, et al.
Cell (2023) Vol. 186, Iss. 25, pp. 5536-5553.e22
Open Access | Times Cited: 51
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, et al.
Blood (2008) Vol. 111, Iss. 7, pp. 3778-3792
Open Access | Times Cited: 225
Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients
Carlo Cota, Esmeralda Vale, Isabel Viana, et al.
The American Journal of Surgical Pathology (2009) Vol. 34, Iss. 1, pp. 75-87
Closed Access | Times Cited: 197
Plasmacytoid Dendritic Cells
Armin G. Jegalian, Fabio Facchetti, Elaine S. Jaffe
Advances in Anatomic Pathology (2009) Vol. 16, Iss. 6, pp. 392-404
Open Access | Times Cited: 181
CD4+/CD56+ Hematodermic Tumor
Marco Herling, Dan Jones
American Journal of Clinical Pathology (2007) Vol. 127, Iss. 5, pp. 687-700
Open Access | Times Cited: 177
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
Francine Garnache‐Ottou, Jean Feuillard, Christophe Ferrand, et al.
British Journal of Haematology (2009) Vol. 145, Iss. 5, pp. 624-636
Open Access | Times Cited: 175
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients
Fanny Julia, Tony Petrella, M. Beylot‐Barry, et al.
British Journal of Dermatology (2013) Vol. 169, Iss. 3, pp. 579-586
Closed Access | Times Cited: 173
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli, Zhiying Esther Hou, Priscilla N. Kelly, et al.
Cancer Cell (2016) Vol. 30, Iss. 5, pp. 764-778
Open Access | Times Cited: 143
Blastic Plasmacytoid Dendritic Cell Neoplasms
Fanny Julia, Stéphane Dalle, Gérard Duru, et al.
The American Journal of Surgical Pathology (2014) Vol. 38, Iss. 5, pp. 673-680
Closed Access | Times Cited: 129
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Blastic plasmacytoid dendritic cell neoplasm
Fabio Facchetti, Marco Ungari, D. Marocolo, et al.
Hematology Meeting Reports (formerly Haematologica Reports) (2009) Vol. 3, Iss. 3, pp. 145-147
Closed Access | Times Cited: 125
Natural killer cell neoplasms
Xiayuan Liang, Douglas K. Graham
Cancer (2008) Vol. 112, Iss. 7, pp. 1425-1436
Open Access | Times Cited: 109
Translational Applications of Flow Cytometry in Clinical Practice
David L. Jaye, Robert A. Bray, Howard M. Gebel, et al.
The Journal of Immunology (2012) Vol. 188, Iss. 10, pp. 4715-4719
Open Access | Times Cited: 104
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Kamel Laribi, Alix Baugier de Materre, Mohamad Sobh, et al.
Blood Advances (2020) Vol. 4, Iss. 19, pp. 4838-4848
Open Access | Times Cited: 58
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm
Wei Wang, Joseph D. Khoury, Roberto N. Miranda, et al.
Haematologica (2020) Vol. 106, Iss. 4, pp. 1047-1055
Open Access | Times Cited: 54
CD4+/CD56+ Hematodermic Neoplasm (“Blastic Natural Killer Cell Lymphoma”)
Monika Pilichowska, Mark D. Fleming, Jack L. Pinkus, et al.
American Journal of Clinical Pathology (2007) Vol. 128, Iss. 3, pp. 445-453
Open Access | Times Cited: 79
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
Kamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 8, pp. 1357-1367
Open Access | Times Cited: 57
BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells
Leonardo Boiocchi, Silvia Lonardi, William Vermi, et al.
Blood (2013) Vol. 122, Iss. 2, pp. 296-297
Open Access | Times Cited: 55
Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 52
Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti‐CD22 antibodies to peripheral blood dendritic cells
Edmunds Reineks, Ebenezer Osei, Arlene S. Rosenberg, et al.
Cytometry Part B Clinical Cytometry (2009) Vol. 76B, Iss. 4, pp. 237-248
Open Access | Times Cited: 56
Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm
Nikhil Sangle, Robert L. Schmidt, Jay Patel, et al.
Modern Pathology (2014) Vol. 27, Iss. 8, pp. 1137-1143
Open Access | Times Cited: 48
Immunophenotypic Analysis of Myeloperoxidase-Negative Leukemia Cutis and Blastic Plasmacytoid Dendritic Cell Neoplasm
Danielle M. P. Cronin, Tracy I. George, Kaaren K. Reichard, et al.
American Journal of Clinical Pathology (2012) Vol. 137, Iss. 3, pp. 367-376
Open Access | Times Cited: 45
Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation
Fatima Hamadeh, Amad Awadallah, Howard Meyerson, et al.
Cytometry Part B Clinical Cytometry (2019) Vol. 98, Iss. 1, pp. 43-51
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top